CROCE', Saveria
 Distribuzione geografica
Continente #
NA - Nord America 7962
EU - Europa 4478
AS - Asia 544
SA - Sud America 17
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 7
Totale 13038
Nazione #
US - Stati Uniti d'America 7838
PL - Polonia 1029
IT - Italia 919
SE - Svezia 810
UA - Ucraina 595
DE - Germania 299
CN - Cina 254
BG - Bulgaria 187
FI - Finlandia 183
TR - Turchia 161
IE - Irlanda 145
CA - Canada 120
GB - Regno Unito 110
FR - Francia 52
BE - Belgio 49
VN - Vietnam 42
RU - Federazione Russa 40
NL - Olanda 17
IN - India 16
IR - Iran 11
EG - Egitto 10
EU - Europa 10
ID - Indonesia 10
PH - Filippine 10
KR - Corea 9
RO - Romania 9
CH - Svizzera 8
HK - Hong Kong 8
ES - Italia 7
IL - Israele 7
AR - Argentina 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AU - Australia 5
BR - Brasile 5
DK - Danimarca 5
CL - Cile 4
JP - Giappone 4
KE - Kenya 4
HR - Croazia 3
TW - Taiwan 3
BD - Bangladesh 2
CU - Cuba 2
GR - Grecia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
SI - Slovenia 2
TH - Thailandia 2
AT - Austria 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
IQ - Iraq 1
LK - Sri Lanka 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SG - Singapore 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 13038
Città #
Warsaw 1026
Woodbridge 969
Fairfield 933
Ann Arbor 875
Chandler 828
Houston 817
Jacksonville 554
Wilmington 459
Seattle 398
Ashburn 391
Trieste 319
Cambridge 304
Princeton 259
Sofia 187
Izmir 151
Dublin 141
Toronto 101
Beijing 86
Dearborn 79
San Diego 66
Falls Church 58
Boardman 53
Brussels 46
Venezia 42
Dong Ket 40
Redmond 40
Redwood City 38
Milan 37
Des Moines 36
Udine 28
Chicago 27
Krefeld 27
Verona 23
Bremen 20
Grafing 20
Mestre 19
Norwalk 19
Phoenix 17
Düsseldorf 15
Jinan 15
Kunming 15
Fremont 14
Rome 14
Ottawa 13
Buffalo 12
Nanchang 12
Nanjing 12
Guangzhou 10
Hefei 10
London 9
Shenyang 9
Fuzhou 8
Helsinki 8
Menlo Park 8
Taiyuan 8
Gattaran 7
Jakarta 7
Palermo 7
San Vito Al Tagliamento 7
Alba 6
Central 6
Kocaeli 6
Maniago 6
New York 6
Padova 6
Stockholm 6
Tel Aviv 6
Wuhan 6
Basel 5
Derby 5
Munro 5
New Haven 5
Sacile 5
Auburn Hills 4
Hebei 4
Morbegno 4
Philadelphia 4
Rottweil 4
San Giorgio A Cremano 4
Seoul 4
Venice 4
Alfa 3
Amsterdam 3
Bangalore 3
Barcelona 3
Belluno 3
Berlin 3
Bologna 3
Budrio 3
Chengdu 3
Copenhagen 3
Hangzhou 3
Kraków 3
Linköping 3
Mcallen 3
Mumbai 3
Munich 3
Piemonte 3
Pordenone 3
San Francisco 3
Totale 9921
Nome #
MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response 359
The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis 341
Transcriptional Up-Regulation of APE1/Ref-1 in hepatic tumor: Role in hepatocytes resistance to oxidative stress and apoptosis 300
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma 280
Adverse reactions of direct-acting antiviral agents in HCV patients: Our experience 274
Evaluation of spleen stiffness in healthy volunteers using point shear wave elastography 242
MicroRNAs as Regulators of Neo-Angiogenesis in Hepatocellular Carcinoma 240
The Role of Liver and Spleen Elastography in the Screening of Esophageal Varices in Patients with Liver Cirrhosis: Do We Really Need Endoscopy? 233
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma 232
HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers 176
Gut microbiota characterisation in obese patients before and after bariatric surgery 172
Role of SERPINB3 like serological and molecular biomarker into NASH development and progression 160
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 159
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 155
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma. 149
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 145
null 145
Identification and evaluation of novel non-invasive biomarkers for non-alcoholic fatty liver disease 145
null 143
1H-NMR Spectroscopic Studies of Lipid Extracts from Human Fatty Liver 142
CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response 142
NOVEL BIOMARKERS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN A HIGHLY RISK NAFLD COHORT in IFSO 2017 22(nd) World Congress 136
Cohort effect of HCV infection in liver cirrhosis assessed by a 25 years study 135
TACE with cone beam computed tomography is more effective than traditional technique in BCLC A HCC patients ineligible to surgery 133
A new insight on the stem cell growth factor beta as astrong predictor of therapy response in hepatocellular carcinoma 133
null 132
Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. 132
Anatomy of Basal Ganglia and Thalamus 132
null 129
null 128
Hepatitis B virus genotypes, core promoter variants, and precore stop codonvariants in patients infected chronically in North-Eastern Italy. 128
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients 128
Treatment options in Western hepatocellular carcinoma: A prospective study of 224 patients 125
null 125
Hepatic cancer stem cells and drug resistance: relevance in targeted therapies of hepatocellular carcinoma 124
Clinical patterns of hepatocellular carcinoma in non alcoholic fatty liver disease: A multicenter prospective study 123
A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects 120
null 119
PREVALENCE OF CHRONIC LIVER-DISEASE IN THE GENERAL-POPULATION OF NORTHERN ITALY - THE DIONYSOS STUDY 117
Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis 116
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 115
The Next Generation Sequencing (NGS) platform in the assessment of the gut microbiota in bariatric surgery. 115
Evaluation with contrast enhanced US of perfusion changes in untreatable hepatocellular carcinoma after thalidomide administration: preliminary results 112
null 110
Bariatric surgery drives major rearrangements of the intestinal microbiota including the biofilm composition. 110
Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue and liver diseases 109
null 109
HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection 108
null 107
Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology. 2009 Oc FI, 9;9:75. 107
The plasticity of the stem cells in the hepatocarcinogenesis and metastasis: study in vitro and in vivo 107
null 105
Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1 105
Clinical update on non-alcoholic fatty liver disease and steatohepatitis 103
null 101
null 101
Visual impairments and attention in parkinson's disease 101
null 100
Distribution of stem cells and cancer stem cells markers in liver pathologies and their indication to the response of therapy 100
Deep brain stimulation of the subthalamus: Neuropsychological effects 98
null 96
Stem cells in the development of hepatocellular carcinoma: identification and expression 95
Human leucocyte interferon-alpha in the treatment of chronic hepatitis C 94
MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma 93
Cross talk between multipotent stem-like cells and cancer cells in hepatocellular carcinoma 93
Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease 92
Clinical and virological features of acute HBV-related hepatitis in southern vietnam 91
null 90
null 89
A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients 89
Characterization of focal liver lesions by pulse inversion harmonic imaging (PIHI) with Levovist in patients with cirrhosis. 87
null 87
High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study 85
Severity of liver disease with different hepatitis C viral clones. 84
Cirrosi biliare primitiva (CBP) asintomatica: trattamento con acido ursidesossicolico (UDCA). Risultati preliminari dopo 12 mesi. 83
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 80
null 79
null 78
Analysis of p53 and ras gene mutations in hepatocellular carcinoma from a Western country 75
null 75
Incidence and natural history of hepatocellular carcinoma and liver cirrhosis in Italy. A lesson from Trieste 70
Evaluation of liver parenchymal blood flow with contrast-enhanced US: preliminary results in healthy and cirrhotic patients 70
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know 67
Variazioni della perfusione dell’epatocarcinoma dopo trattamento con talidomide 66
Spontaneous rectal perforation in a patient with SARS–CoV-2 infection 66
null 64
Hepatocellular carcinoma in the non-cirrhotic liver in Northern Italy: a retrospective study 64
null 63
Presence of Japanese-type HCV in a North-East Italian population 62
Evidence of different outcome of Interferon therapy in patients infected by different HCV strains 60
Epidemiologia del carcinoma epatocellulare 59
Spontaneous porto-femoral shunting in long-standing portal hypertension 58
HCV infectivity, genotype pattern and severity of chronic liver disease in the general population of Northern Italy. 57
Prevalence of hepatitis C virus genotype infection in the general population of Northern Italy: relationship with the severity of chronic liver disease. 56
Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test 56
Elastography: where are we now? 55
Antibody pattern of HCV infection and hepatocellular carcinoma in Itakly: A case control study 53
null 53
Rapid identification system of frontal dysfunction in subclinical hepatic encephalopathy 53
The role of elastography in alcoholic liver disease: fibrosis staging and confounding factors, a review of the current literature 53
Totale 11812
Categoria #
all - tutte 21937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018292 0000 00 00 517912042
2018/20191415 267115116 3136 11128 40192513236
2019/20202988 153132150522 280439 280315 24716220999
2020/20212303 186141193253 213233 184198 106215120261
2021/20221868 6098226204 58133 103126 213167103377
2022/20232275 216280167346 224454 64269 255000
Totale 13673